Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021

Morbidity and Mortality Weekly Report - Tập 70 Số 13 - Trang 495-500
Mark G. Thompson1, Jefferey L. Burgess2, Allison L. Naleway3, Harmony L. Tyner4, Sarang K. Yoon5, Jennifer K. Meece6, Lauren E.W. Olsho7, Alberto J. Caban‐Martinez8, Ashley Fowlkes1, Karen Lutrick2, Jennifer L. Kuntz3, Kayan Dunnigan9, Marilyn J. Odean10, Kurt T. Hegmann5, Elisha Stefanski6, Laura Edwards7, Natasha Schaefer Solle8, Lauren Grant1, Katherine Ellingson2, Holly C. Groom3, Tnelda Zunie9, Matthew S. Thiese5, Lynn Ivacic6, Meredith G. Wesley7, Julie Mayo Lamberte1, Xiaoxiao Sun2, Michael Smith9, Andrew L. Phillips5, Kimberly Groover7, Young M. Yoo1, Joe K. Gerald2, Rachel T. Brown5, Meghan K. Herring7, Gregory Joseph1, Shawn C. Beitel2, Tyler Morrill7, Josephine Mak1, Patrick Rivers2, Katherine M. Harris7, Danielle Rentz Hunt7, Melissa L Arvay1, Preeta K. Kutty1, Alicia M. Fry1, Manjusha Gaglani9,11
1CDC COVID-19 Response Team
2Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona
3Kaiser Permanente Northwest Center for Health Research, Portland, Oregon
4St. Luke's, Duluth, Minnesota;
5University of Utah, Salt Lake City, Utah.
6Marshfield Clinic Research Laboratory, Marshfield, Wisconsin;
7Abt Associates, Inc., Atlanta, Georgia;
8Leonard M. Miller School of Medicine, University of Miami, Florida;
9Baylor Scott & White Health, Temple, Texas;
10Whiteside Institute for Clinical Research, St. Luke's, Duluth, Minnesota;
11Texas A&M University College of Medicine, College Station, Texas

Tóm tắt

Từ khóa


Tài liệu tham khảo

Baden, 2021, Efficacy and safety of the mRNA-123 SARS-CoV-2 vaccine., N Engl J Med, 384, 403, 10.1056/NEJMoa2035389

Polack, 2020, Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine., N Engl J Med, 383, 2603, 10.1056/NEJMoa2034577

Pawlowski C, Lenehan P, Puranik A, FDA-authorized COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system. medRxiv [Preprint posted online February 27, 2021]. https://www.medrxiv.org/content/10.1101/2021.02.15.21251623v3

Hall VJ, Foulkes S, Saei A, Effectiveness of BNT162b2 mRNA vaccine against infection and COVID-19 vaccine coverage in healthcare workers in England, multicentre prospective cohort study (the SIREN Study). Lancet [Preprint posted online February 22, 2021]. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3790399

Amit, 2021, Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients., Lancet, 397, 875, 10.1016/S0140-6736(21)00448-7

Byambasuren O, Cardona M, Bell K, Clark J, McLaws M-L, Glasziou P. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis. medRxiv [Preprint posted online September 13, 2020]. https://www.medrxiv.org/content/10.1101/2020.05.10.20097543v3

Skowronski, 2021, Safety and efficacy of the BNT162b2 mRNA Covid-19 Vaccine., N Engl J Med

Daniel, 2021, Early evidence of the effect of SARS-CoV-2 vaccine at one medical center., N Engl J Med, 10.1056/NEJMc2102153

Keehner, 2021, SARS-CoV-2 infection after vaccination in health care workers in California., N Engl J Med, 10.1056/NEJMc2101927

McCulloch, 2020, Comparison of unsupervised home self-collected midnasal swabs with clinician-collected nasopharyngeal swabs for detection of SARS-CoV-2 infection., JAMA Netw Open, 3, e2016382, 10.1001/jamanetworkopen.2020.16382